The Longevist

28 posts

The Longevist banner
The Longevist

The Longevist

@thelongevist

Posts about longevity, peptides and human optimization

Katılım Ekim 2022
5 Takip Edilen58 Takipçiler
Sabitlenmiş Tweet
The Longevist
The Longevist@thelongevist·
Here's Bryan Johnson's 44% jet lag recovery protocol: - The protocol: 300mg slow-release caffeine in the morning & 3mg melatonin before bed after eastbound travel - The original study used 5mg melatonin, but Johnson suspects lower doses (0.3–0.5mg) may be sufficient & potentially more effective - Johnson believes circadian disruption affects cortisol, recovery, cognition and metabolic health, which is why he treats jet lag as a biological stressor - Research shows timed caffeine and melatonin can reduce jet lag symptoms, improve alertness and speed circadian realignment after long-haul flights
The Longevist tweet mediaThe Longevist tweet media
Bryan Johnson@bryan_johnson

The new jet lag recovery protocol worked. > I flew to Australia > met Kate's fam > became part of the fam ftw > flew home > jet lag broke my body's clock > felt broken inside > 300 mg of caffeine in am > 3 mg of melatonin before bed Watched my body's clock come back online, live, via blood glucose. Protocol accelerated body clock synchronization.

English
1
1
4
7.6K
vittorio
vittorio@IterIntellectus·
this is actually incredible a full body ultrasound scanner that takes 60 seconds instead of spending an hour in an MRI tube, without radiation, hospitals or a $2000 bill soon you’ll just walk into a health spa, order a coffee, step into the pod, and walk out with a 3D map of your body the future is finally starting to look like the future
vittorio tweet mediavittorio tweet media
Midjourney@midjourney

A technical dive inside our new "Midjourney Scanner"

English
253
1.2K
15.4K
1.3M
Midjourney
Midjourney@midjourney·
A technical dive inside our new "Midjourney Scanner"
Français
1.2K
3.1K
27.2K
10.1M
The Longevist
The Longevist@thelongevist·
Midjourney pivoted to healthcare, full information : - It launched “Midjourney Medical,” building a full-body ultrasound CT scanner that lowers users into water and scans them with ultrasonic waves - The goal is to get 3D body maps in 60 secs, using hundreds of thousands of sensor elements + massive compute to reconstruct tissue density/stiffness - First use case is body composition mapping, not diagnosis, FDA approval is needed for broader medical claims - Big ambition is upto 50,000 scanners by 2031 and up to 1B scans/month, but radiologists warn about false positives, privacy & over-scanning risks
The Longevist tweet mediaThe Longevist tweet media
English
1
0
0
267
OpenAI
OpenAI@OpenAI·
GPT-5.5 Instant is now on par with our frontier Thinking models for health-related questions. Every week, more than 230 million people turn to ChatGPT with health and wellness questions, and GPT-5.5 Instant is better at recognizing when urgent care may be needed, asking for relevant context, explaining uncertainty, and making complex information easier to understand. Because GPT-5.5 Instant is available to all free users in ChatGPT, these improvements can help more people. Physician-led evaluation was critical to making these major intelligence gains.
English
223
273
3.9K
503.8K
OpenAI
OpenAI@OpenAI·
Together with researchers at Boston Children’s Hospital and Harvard, we published a study in NEJM AI showing how o3 Deep Research helped clinicians revisit previously unsolved rare pediatric disease cases, and find answers for families who had waited years.
English
184
310
2.7K
2.5M
The Longevist
The Longevist@thelongevist·
OpenAI solved hardest childhood genetic diseases : - Boston Children’s Hospital, Harvard & OpenAI used o3 Deep Research to reanalyze 376 previously unsolved rare genetic disease cases - The model reviewed de-identified clinical/genomic data, HPO terms, family inheritance patterns, variant effects, ClinVar evidence & scientific literature - After expert review + CLIA lab confirmation, physicians established 18 diagnoses, a 4.8% extra diagnostic yield - Before unsolved cases, the workflow recovered correct diagnoses in 48/51 solved rare-disease cases and 45/57 neuromuscular cases
The Longevist tweet mediaThe Longevist tweet media
English
0
0
0
126
Jake Gilman
Jake Gilman@jakeglmn·
Jet lag usually ruins the first few days of every trip. But Dana White says he beats it completely without melatonin or sleeping pills. Just two things he does on every flight. Here's the science behind why it works (thread):
English
20
43
923
704.1K
Bryan Johnson
Bryan Johnson@bryan_johnson·
The new jet lag recovery protocol worked. > I flew to Australia > met Kate's fam > became part of the fam ftw > flew home > jet lag broke my body's clock > felt broken inside > 300 mg of caffeine in am > 3 mg of melatonin before bed Watched my body's clock come back online, live, via blood glucose. Protocol accelerated body clock synchronization.
Bryan Johnson tweet media
English
90
33
1K
178.4K
CNN
CNN@CNN·
A new clinical trial found that taking omega-3 supplements did nothing to improve memory, cognition or brain cell loss. cnn.it/44nqiCM
English
422
1.5K
4.9K
1.2M
The Longevist
The Longevist@thelongevist·
How effective are Omega-3 supplements for brain? - Omega-3s (DHA & EPA) are critical for brain health and are found in fish oil and algae oil - Some studies link higher omega-3 levels to lower risks of cognitive decline and dementia - However, large clinical trials have produced mixed results with limited benefits seen in the general population - Researchers believe omega-3s may work best before significant brain damage occurs or in people with low baseline omega-3 levels - Omega-3s support brain health, but they're not a proven cure or guaranteed shield against Alzheimer's
The Longevist tweet mediaThe Longevist tweet media
English
0
0
1
171
OpenAI
OpenAI@OpenAI·
GPT-5.4 helped drive a medicinal chemistry project from literature review to a validated experimental result. Paired with Molecule.one’s Maria AI and specialized lab, the model proposed an unexpected way to improve a widely used reaction in drug discovery.
English
181
311
3.1K
454.1K
The Longevist
The Longevist@thelongevist·
OpenAI made a real scientific discovery in a chemistry lab : - Team targeted a palladium catalyzed cross coupling reaction, a core step used to synthesize drug molecules - AI analyzed reaction pathways, catalyst loading, solvent selection and temperature conditions to identify higher yield configurations - The system proposed novel experimental conditions that human chemists had not prioritized, leading to measurable reaction improvements in the lab - Every AI generated hypothesis was tested experimentally, creating a closed loop workflow between AI reasoning and real world chemistry
The Longevist tweet mediaThe Longevist tweet media
English
0
0
1
287
Shining Science
Shining Science@ShiningScience·
The theory that Alzheimer's is caused by plaques in the brain is now being challenged… Scientists redefine Alzheimer’s as an autoimmune disease where the brain’s defense system mistakenly attacks healthy cells, opening a new frontier for treatment. For decades, the medical community viewed the buildup of beta-amyloid plaques as the primary culprit behind Alzheimer’s disease. However, a groundbreaking new theory based on 30 years of research suggests that Alzheimer’s is actually a complex autoimmune condition. In this model, beta-amyloid is not a destructive waste product, but a vital component of the brain's immune system designed to fight off injury and infection. The problem arises because the fat molecules in bacterial membranes closely resemble those in brain cell membranes, causing the immune system to mistakenly attack the very organ it is meant to protect. This autoimmune misfire triggers a chronic, progressive loss of brain function that eventually leads to dementia. By reclassifying Alzheimer’s as a disorder of the immune system, researchers are now looking beyond traditional plaque-clearing drugs to explore therapies that regulate the brain’s immune pathways. This shift offers a beacon of hope for more effective treatments, aligning Alzheimer’s with other recognized autoimmune diseases like rheumatoid arthritis and multiple sclerosis, and potentially unlocking a new era of neurological care. source: Weaver, D. F. (2025). Alzheimer’s disease as an autoimmune disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.
Shining Science tweet media
English
15
134
333
30.1K
Massimo
Massimo@Rainmaker1973·
The popular joint supplement glucosamine has been linked to a 25% faster progression from mild cognitive impairment to Alzheimer’s disease. A major new study published in Nature Metabolism has revealed a concerning association between glucosamine, a widely used over-the-counter supplement for joint pain, and accelerated cognitive decline. Researchers at the University of Florida analyzed 12 years of electronic health records and found that patients with mild cognitive impairment (MCI) who regularly took glucosamine were 25% more likely to progress to full Alzheimer’s disease compared to non-users. The risks extended further: among individuals already diagnosed with dementia, glucosamine use was associated with a 25% higher mortality risk. Scientists believe the supplement may worsen the condition because glucosamine readily crosses the blood-brain barrier and fuels an overactive “sugar-tagging” (hyperglycosylation) pathway in vulnerable brains, aggravating metabolic dysfunction. Importantly, this risk appears to be specific to people whose brains are already undergoing neurodegeneration. In healthy individuals, some earlier research has actually suggested potential protective effects. However, with tens of millions of people — many of them older adults — taking glucosamine for joint health, these findings highlight the need for caution and further clinical trials. [Hawkinson, T. R., Gentry, M. S., & Sun, R. et al. (2026). Hyperglycosylation is a metabolic driver of Alzheimer’s disease. Nature Metabolism. DOI: 10.1038/s42255-026-01538-4]
Massimo tweet media
English
56
369
1.3K
147.1K
The Longevist
The Longevist@thelongevist·
New study raises Alzheimer's concerns around a popular joint supplement : - University of Florida researchers analyzed 12 years of health records and found glucosamine users with MCI were 25% more likely to develop Alzheimer's - In people already diagnosed with dementia, glucosamine use was linked to a 25% higher mortality risk - Researchers identified hyperglycosylation ("sugar-tagging" of proteins) as a potential driver of the disease - Glucosamine crosses the blood-brain barrier and may worsen metabolic dysfunction in vulnerable brains
The Longevist tweet mediaThe Longevist tweet media
English
0
0
0
210
Chubby♨️
Chubby♨️@kimmonismus·
World-first: Scientists just treated the first human with a therapy designed to make old cells young again For the first time, a person has received a gene therapy aimed at “partially reprogramming” aging cells, essentially nudging them back toward a younger state without turning them into stem cells. The trial, run by Life Biosciences, targets glaucoma by trying to regenerate damaged optic nerve cells in the eye. The huge question now: can cellular rejuvenation work safely in humans? It may be one of the most important first tests of whether the biology of aging can be therapeutically reversed.
Chubby♨️ tweet mediaChubby♨️ tweet media
English
20
58
649
34K
Massimo
Massimo@Rainmaker1973·
The world’s first anti-aging gene therapy has been injected into a human for the first time. In June 2026, Boston-based Life Biosciences announced that the first patient received a dose of their experimental therapy ER-100 in a Phase 1 clinical trial. The treatment uses partial epigenetic reprogramming by delivering three Yamanaka factors (OCT4, SOX2, and KLF4) to restore aged or damaged cells to a more youthful state. It is currently being tested as an injection into the eye for age-related optic neuropathies, including open-angle glaucoma and non-arteritic anterior ischemic optic neuropathy (NAION). This milestone marks the first time partial cellular reprogramming technology has been administered to a human. While the current trial focuses on safety and vision outcomes in the eye, it represents a major step toward broader anti-aging applications. [Life Biosciences. (2026). Life Biosciences Announces First Patient Dosed in Phase 1 Trial of ER-100 for Optic Neuropathies. Company Press Release, June 9, 2026]
Massimo tweet media
English
79
418
1.9K
252.3K
The Longevist
The Longevist@thelongevist·
Person received world's first age-reversal therapy : - Boston-based Life Biosciences treated the first patient with a gene therapy designed to make aging cells behave younger again - The therapy uses 3 "Yamanaka factors" (OSK) that can partially reset a cell's epigenetic age without turning it into a stem cell - The first trial targets optic neuropathies by injecting the treatment directly into the eye, followed by a 6 months safety evaluation - In animal studies, similar cellular reprogramming restored vision, rejuvenated tissues & reversed biological markers of aging
The Longevist tweet mediaThe Longevist tweet media
English
1
5
10
5.1K